169 related articles for article (PubMed ID: 38665433)
1. Nucleoside supplements as treatments for mitochondrial DNA depletion syndrome.
Dombi E; Marinaki T; Spingardi P; Millar V; Hadjichristou N; Carver J; Johnston IG; Fratter C; Poulton J
Front Cell Dev Biol; 2024; 12():1260496. PubMed ID: 38665433
[No Abstract] [Full Text] [Related]
2. In vitro supplementation with dAMP/dGMP leads to partial restoration of mtDNA levels in mitochondrial depletion syndromes.
Bulst S; Abicht A; Holinski-Feder E; Müller-Ziermann S; Koehler U; Thirion C; Walter MC; Stewart JD; Chinnery PF; Lochmüller H; Horvath R
Hum Mol Genet; 2009 May; 18(9):1590-9. PubMed ID: 19221117
[TBL] [Abstract][Full Text] [Related]
3. Increased dNTP pools rescue mtDNA depletion in human POLG-deficient fibroblasts.
Blázquez-Bermejo C; Carreño-Gago L; Molina-Granada D; Aguirre J; Ramón J; Torres-Torronteras J; Cabrera-Pérez R; Martín MÁ; Domínguez-González C; de la Cruz X; Lombès A; García-Arumí E; Martí R; Cámara Y
FASEB J; 2019 Jun; 33(6):7168-7179. PubMed ID: 30848931
[TBL] [Abstract][Full Text] [Related]
4. Defects in maintenance of mitochondrial DNA are associated with intramitochondrial nucleotide imbalances.
Ashley N; Adams S; Slama A; Zeviani M; Suomalainen A; Andreu AL; Naviaux RK; Poulton J
Hum Mol Genet; 2007 Jun; 16(12):1400-11. PubMed ID: 17483096
[TBL] [Abstract][Full Text] [Related]
5. Nucleoside supplementation modulates mitochondrial DNA copy number in the dguok -/- zebrafish.
Munro B; Horvath R; Müller JS
Hum Mol Genet; 2019 Mar; 28(5):796-803. PubMed ID: 30428046
[TBL] [Abstract][Full Text] [Related]
6. The nucleotide prodrug CERC-913 improves mtDNA content in primary hepatocytes from DGUOK-deficient rats.
Vanden Avond MA; Meng H; Beatka MJ; Helbling DC; Prom MJ; Sutton JL; Slick RA; Dimmock DP; Pertusati F; Serpi M; Pileggi E; Crutcher P; Thomas S; Lawlor MW
J Inherit Metab Dis; 2021 Mar; 44(2):492-501. PubMed ID: 33368311
[TBL] [Abstract][Full Text] [Related]
7. Combined use of Saccharomyces cerevisiae, Caenorhabditis elegans and patient fibroblasts leads to the identification of clofilium tosylate as a potential therapeutic chemical against POLG-related diseases.
Pitayu L; Baruffini E; Rodier C; Rötig A; Lodi T; Delahodde A
Hum Mol Genet; 2016 Feb; 25(4):715-27. PubMed ID: 26692522
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial DNA maintenance defects.
El-Hattab AW; Craigen WJ; Scaglia F
Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1539-1555. PubMed ID: 28215579
[TBL] [Abstract][Full Text] [Related]
9. Quantitative evaluation of the mitochondrial DNA depletion syndrome.
Dimmock D; Tang LY; Schmitt ES; Wong LJ
Clin Chem; 2010 Jul; 56(7):1119-27. PubMed ID: 20448188
[TBL] [Abstract][Full Text] [Related]
10. The clinical diagnosis of POLG disease and other mitochondrial DNA depletion disorders.
Cohen BH; Naviaux RK
Methods; 2010 Aug; 51(4):364-73. PubMed ID: 20558295
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial DNA maintenance disorders in 102 patients from different parts of Russia: Mutational spectrum and phenotypes.
Bychkov IO; Itkis YS; Tsygankova PG; Krylova TD; Mikhaylova SV; Klyushnikov SA; Pechatnikova NL; Degtyareva AV; Nikolaeva EA; Seliverstov YA; Kurbatov SA; Dadali EL; Rudenskaya GE; Illarioshkin SN; Zakharova EY
Mitochondrion; 2021 Mar; 57():205-212. PubMed ID: 33486010
[TBL] [Abstract][Full Text] [Related]
12. Clinical, biochemical, cellular and molecular characterization of mitochondrial DNA depletion syndrome due to novel mutations in the MPV17 gene.
Uusimaa J; Evans J; Smith C; Butterworth A; Craig K; Ashley N; Liao C; Carver J; Diot A; Macleod L; Hargreaves I; Al-Hussaini A; Faqeih E; Asery A; Al Balwi M; Eyaid W; Al-Sunaid A; Kelly D; van Mourik I; Ball S; Jarvis J; Mulay A; Hadzic N; Samyn M; Baker A; Rahman S; Stewart H; Morris AA; Seller A; Fratter C; Taylor RW; Poulton J
Eur J Hum Genet; 2014 Feb; 22(2):184-91. PubMed ID: 23714749
[TBL] [Abstract][Full Text] [Related]
13. Defects in mitochondrial DNA replication and human disease.
Copeland WC
Crit Rev Biochem Mol Biol; 2012; 47(1):64-74. PubMed ID: 22176657
[TBL] [Abstract][Full Text] [Related]
14. Administration of deoxyribonucleosides or inhibition of their catabolism as a pharmacological approach for mitochondrial DNA depletion syndrome.
Cámara Y; González-Vioque E; Scarpelli M; Torres-Torronteras J; Caballero A; Hirano M; Martí R
Hum Mol Genet; 2014 May; 23(9):2459-67. PubMed ID: 24362886
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options.
El-Hattab AW; Scaglia F
Neurotherapeutics; 2013 Apr; 10(2):186-98. PubMed ID: 23385875
[TBL] [Abstract][Full Text] [Related]
16. Depletion of mitochondrial DNA in fibroblast cultures from patients with POLG1 mutations is a consequence of catalytic mutations.
Ashley N; O'Rourke A; Smith C; Adams S; Gowda V; Zeviani M; Brown GK; Fratter C; Poulton J
Hum Mol Genet; 2008 Aug; 17(16):2496-506. PubMed ID: 18487244
[TBL] [Abstract][Full Text] [Related]
17. Analysis of mutant DNA polymerase gamma in patients with mitochondrial DNA depletion.
Taanman JW; Rahman S; Pagnamenta AT; Morris AA; Bitner-Glindzicz M; Wolf NI; Leonard JV; Clayton PT; Schapira AH
Hum Mutat; 2009 Feb; 30(2):248-54. PubMed ID: 18828154
[TBL] [Abstract][Full Text] [Related]
18. [Mitochondrial disease and mitochondrial DNA depletion syndromes].
Huang CC; Hsu CH
Acta Neurol Taiwan; 2009 Dec; 18(4):287-95. PubMed ID: 20329599
[TBL] [Abstract][Full Text] [Related]
19. Altered gene transcription profiles in fibroblasts harboring either TK2 or DGUOK mutations indicate compensatory mechanisms.
Villarroya J; de Bolós C; Meseguer A; Hirano M; Vilà MR
Exp Cell Res; 2009 May; 315(8):1429-38. PubMed ID: 19265691
[TBL] [Abstract][Full Text] [Related]
20. Autosomal disorders of mitochondrial DNA maintenance.
Van Goethem G
Acta Neurol Belg; 2006 Jun; 106(2):66-72. PubMed ID: 16898256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
